Variability in calcium, phosphorus, and parathyroid hormone in patients on hemodialysis

Area of Science:

• Nephrology
• Clinical Chemistry

Background:

• Routine monitoring of calcium, phosphorus, and parathyroid hormone (PTH) is crucial for chronic hemodialysis patients.
• Treatment adjustments are based on achieving target lab values to improve patient outcomes.
• Limited research exists on the variability of these key parameters in hemodialysis patients.

Purpose of the Study:

• To prospectively investigate the session-to-session variability of calcium, phosphorus, and PTH levels in chronic hemodialysis patients.
• To assess the impact of this laboratory value variability on clinical decision-making.
• To compare month-to-month variability with session-to-session variability over a year.

Main Methods:

• Prospective study involving 35 patients undergoing chronic hemodialysis.
• Measurement of calcium, phosphorus, and PTH levels over a one-month period.
• Analysis of variability using the coefficient of variation (CV) and assessment of clinical decision changes.

Main Results:

• Significant session-to-session variability observed in phosphorus (CV 0.19) and PTH (CV 0.31).
• Calcium exhibited lower variability (CV 0.05).
• Variability increased during the interdialytic interval.
• Different clinical decisions would have been made for 23.6% (calcium), 41.2% (phosphorus), and 39.7% (PTH) of lab values.
• Session-to-session variability closely mirrored month-to-month variability over a year.

Conclusions:

• High variability in phosphorus and PTH levels is a significant factor in chronic hemodialysis.
• Laboratory value variability frequently influences clinical decision-making in this patient population.
• These findings have implications for patient management and performance-based reimbursement models.